Skip to main content
. Author manuscript; available in PMC: 2024 Jun 27.
Published in final edited form as: Curr Trop Med Rep. 2023 Oct 25;10(4):222–234. doi: 10.1007/s40475-023-00304-w

Table 3.

Algorithm on the management of gHAT according to WHO guidelines

Characteristics of the patient Severe HAT suspected CSF findings First choice treatment
≥ 6 years old, AND ≥ 20 kg body weight No Lumbar puncture not indicated Fexinidazole
Yes ≥ 100 WBC/μL NECT
< 100 WBC/μL Fexinidazole
Lumbar puncture not done Fexinidazole
< 6 years old, OR < 20 kg body weight (fexinida zole contraindicated) Lumbar puncture always indicated ≤ 5 WBC/μL, no CSF tryps Pentamidine
6–99 WBC/μL or CSF tryps NECT
LP not done